Shenglan Yang

1.1k total citations · 2 hit papers
14 papers, 702 citations indexed

About

Shenglan Yang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Shenglan Yang has authored 14 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in Shenglan Yang's work include Inflammasome and immune disorders (3 papers), Respiratory Support and Mechanisms (2 papers) and Long-Term Effects of COVID-19 (2 papers). Shenglan Yang is often cited by papers focused on Inflammasome and immune disorders (3 papers), Respiratory Support and Mechanisms (2 papers) and Long-Term Effects of COVID-19 (2 papers). Shenglan Yang collaborates with scholars based in China and New Zealand. Shenglan Yang's co-authors include Luorui Shang, Fangyuan Zhou, Guangtao Pan, Yuhan Liu, Jinxiao Li, Shuhan Wang, Mengqi Zhang, Jiabin Zhou, Kunmin Xiao and Yuhan Liu and has published in prestigious journals such as Journal of Ethnopharmacology, Biomedicine & Pharmacotherapy and Journal of Experimental & Clinical Cancer Research.

In The Last Decade

Shenglan Yang

14 papers receiving 696 citations

Hit Papers

EMT‐associated microRNAs and their roles in cancer stemne... 2021 2026 2022 2024 2021 2022 50 100 150 200

Peers

Shenglan Yang
Comparison fields: 5 of 85
  • Molecular Biology 412
  • Cancer Research 172
  • Pulmonary and Respiratory Medicine 102
  • Oncology 93
  • Pharmacology 75
Luorui Shang China
Wei‐Jan Wang Taiwan
Min Tan China
Fangfang Liu China
Qi He China
Yifang Li China
Neeraj Kapur United States
Weiji Lin China
Xin Ba China
Luorui Shang China View profile →
Citations per field, relative to Shenglan Yang
Shenglan Yang · 1×
Citations per year, relative to Shenglan Yang
Shenglan Yang · 1×

Countries citing papers authored by Shenglan Yang

Since Specialization
Citations

This map shows the geographic impact of Shenglan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglan Yang more than expected).

Fields of papers citing papers by Shenglan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglan Yang. The network helps show where Shenglan Yang may publish in the future.

Co-authorship network of co-authors of Shenglan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglan Yang. A scholar is included among the top collaborators of Shenglan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglan Yang. Shenglan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
# Title Journal Authors Indexed citations
1 Protein Kinase C Family: Structures, Biological Functions, Diseases, and Pharmaceutical Interventions MedComm Yongqi Li, Yuhan Jiang et al. 1
2 Intestinal Fut2 deficiency exacerbated alcohol‐related liver disease by disrupting nicotinamide metabolism Clinical and Translational Medicine Liuying Chen, Zhongwei Yin et al. 1
3 Association Between Glycated Hemoglobin and Diabetic Retinopathy in Individuals with Diabetes: A Focus on the Modifying Effect of Ambulatory Blood Pressure Clinical Interventions in Aging Shenglan Yang, Hui Liu et al. 1
4 MiR-874-5p targets VDR/NLRP3 to reduce intestinal pyroptosis and improve intestinal barrier damage in sepsis International Immunopharmacology Luorui Shang, Jinxiao Li et al. 8
5 Dachengqi decoction ameliorates sepsis-induced liver injury by inhibiting the TGF-β1/Smad3 pathways Journal of Traditional and Complementary Medicine Guangtao Pan, Yuhan Liu et al. 2
6 Dachengqi decoction alleviates acute lung injury by suppressing HIF-1α-mediated glycolysis Journal of Ethnopharmacology Luorui Shang, Mengqi Zhang et al. 9
7 Herba Patriniae and its component Isovitexin show anti-colorectal cancer effects by inducing apoptosis and cell-cycle arrest via p53 activation Biomedicine & Pharmacotherapy Jinxiao Li, Luorui Shang et al. 19
8 Oridonin promotes endoplasmic reticulum stress via TP53-repressed TCF4 transactivation in colorectal cancer Journal of Experimental & Clinical Cancer Research Fangyuan Zhou, Haiyang Gao et al. 51
9 Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation breakdown → Journal of Ethnopharmacology Luorui Shang, Jinxiao Li et al. 161
10 EMT‐associated microRNAs and their roles in cancer stemness and drug resistance breakdown → Cancer Communications Guangtao Pan, Yuhan Liu et al. 246
11 Emodin Attenuates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis Signaling Pathway In vitro and In vivo Inflammation Yuhan Liu, Jiabin Zhou et al. 53
12 Honokiol alleviates LPS-induced acute lung injury by inhibiting NLRP3 inflammasome-mediated pyroptosis via Nrf2 activation in vitro and in vivo Chinese Medicine Yuhan Liu, Jiabin Zhou et al. 78
13 Assessment of Sequelae of COVID-19 Nearly 1 Year After Diagnosis Frontiers in Medicine Fangyuan Zhou, Meihui Tao et al. 57
14 Long‐term effects of obesity on COVID‐19 patients discharged from hospital Immunity Inflammation and Disease Li Wang, Fangyuan Zhou et al. 15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026